Precision Medicine Versus Population Medicine in Colon Cancer: From Prospects of Prevention, Adjuvant Chemotherapy, and Surveillance

With the advances of technologic revolution that provides new insights into human biology, genetics and cancer, as well as advantages of big data which amasses large amounts of information for us to approach cancer treatment and prevention, we are facing challenges of organically combining data from...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American Society of Clinical Oncology educational book 2018-05, Vol.38 (38), p.220-230
Hauptverfasser: Hall, Michael J, Morris, Arden M, Sun, Weijing
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 230
container_issue 38
container_start_page 220
container_title American Society of Clinical Oncology educational book
container_volume 38
creator Hall, Michael J
Morris, Arden M
Sun, Weijing
description With the advances of technologic revolution that provides new insights into human biology, genetics and cancer, as well as advantages of big data which amasses large amounts of information for us to approach cancer treatment and prevention, we are facing challenges of organically combining data from studies based on general population and information from individual testing and setting out precisional recommendations in cancer diagnosis, prevention, and treatment. We are obligated to accelerate the adaptation of new scientific discoveries into effective treatments and prevention for cancer. In this review, we introduce our opinions on bringing knowledge of precision and population medicine together to guide our clinical practice from the prospects of colorectal cancer prevention, stage III colon cancer adjuvant therapy, and postsurgery surveillance.
doi_str_mv 10.1200/EDBK_200961
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2138633207</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2138633207</sourcerecordid><originalsourceid>FETCH-LOGICAL-c204t-cfdb338f1318f6f340a6558325f0dfd7a5febfa0f506f0ce0f08fafc253746613</originalsourceid><addsrcrecordid>eNpVkMtPwkAQxjdGI4ievJs9mkh1H-22eMMKasRI4uPaLNvZUNJ2625Lwt0_3DYg0dO8fvNl5kPonJJrygi5mdzfPSdtMhL0APVp4EdeFAbicJ_7UQ-dOLciRLARC49RjxPGKedhH33PLajMZabEL5BmKisBf4J1jcNzUzW5rP-NshLHJm87sSwV2Fs8tabAc2tcBap22Oi2gDWU3doQj9NVs5ZljeMlFKZegpXVZohlmeK3xq4hy_NO5xQdaZk7ONvFAfqYTt7jR2_2-vAUj2eeYsSvPaXTBeeRppxGWmjuEymCIOIs0CTVaSgDDQstiQ6I0EQB0STSUisW8NAXgvIButzqVtZ8NeDqpMicgu4IMI1LGOWR4JyRsEWvtqhqf3MWdFLZrJB2k1CSdLYnf2xv6YudcLMoIN2zvz7zHwMdfzA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2138633207</pqid></control><display><type>article</type><title>Precision Medicine Versus Population Medicine in Colon Cancer: From Prospects of Prevention, Adjuvant Chemotherapy, and Surveillance</title><source>MEDLINE</source><source>American Society of Clinical Oncology Online Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Hall, Michael J ; Morris, Arden M ; Sun, Weijing</creator><creatorcontrib>Hall, Michael J ; Morris, Arden M ; Sun, Weijing</creatorcontrib><description>With the advances of technologic revolution that provides new insights into human biology, genetics and cancer, as well as advantages of big data which amasses large amounts of information for us to approach cancer treatment and prevention, we are facing challenges of organically combining data from studies based on general population and information from individual testing and setting out precisional recommendations in cancer diagnosis, prevention, and treatment. We are obligated to accelerate the adaptation of new scientific discoveries into effective treatments and prevention for cancer. In this review, we introduce our opinions on bringing knowledge of precision and population medicine together to guide our clinical practice from the prospects of colorectal cancer prevention, stage III colon cancer adjuvant therapy, and postsurgery surveillance.</description><identifier>ISSN: 1548-8748</identifier><identifier>EISSN: 1548-8756</identifier><identifier>DOI: 10.1200/EDBK_200961</identifier><identifier>PMID: 30231337</identifier><language>eng</language><publisher>United States</publisher><subject>Biomarkers, Tumor ; Chemotherapy, Adjuvant ; Colonic Neoplasms - diagnosis ; Colonic Neoplasms - epidemiology ; Colonic Neoplasms - prevention &amp; control ; Colonic Neoplasms - therapy ; Genetic Predisposition to Disease ; Genetic Testing ; Germ-Line Mutation ; Humans ; Neoplasm Staging ; Population Surveillance ; Precision Medicine - methods ; Treatment Outcome</subject><ispartof>American Society of Clinical Oncology educational book, 2018-05, Vol.38 (38), p.220-230</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c204t-cfdb338f1318f6f340a6558325f0dfd7a5febfa0f506f0ce0f08fafc253746613</citedby><cites>FETCH-LOGICAL-c204t-cfdb338f1318f6f340a6558325f0dfd7a5febfa0f506f0ce0f08fafc253746613</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3716,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30231337$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hall, Michael J</creatorcontrib><creatorcontrib>Morris, Arden M</creatorcontrib><creatorcontrib>Sun, Weijing</creatorcontrib><title>Precision Medicine Versus Population Medicine in Colon Cancer: From Prospects of Prevention, Adjuvant Chemotherapy, and Surveillance</title><title>American Society of Clinical Oncology educational book</title><addtitle>Am Soc Clin Oncol Educ Book</addtitle><description>With the advances of technologic revolution that provides new insights into human biology, genetics and cancer, as well as advantages of big data which amasses large amounts of information for us to approach cancer treatment and prevention, we are facing challenges of organically combining data from studies based on general population and information from individual testing and setting out precisional recommendations in cancer diagnosis, prevention, and treatment. We are obligated to accelerate the adaptation of new scientific discoveries into effective treatments and prevention for cancer. In this review, we introduce our opinions on bringing knowledge of precision and population medicine together to guide our clinical practice from the prospects of colorectal cancer prevention, stage III colon cancer adjuvant therapy, and postsurgery surveillance.</description><subject>Biomarkers, Tumor</subject><subject>Chemotherapy, Adjuvant</subject><subject>Colonic Neoplasms - diagnosis</subject><subject>Colonic Neoplasms - epidemiology</subject><subject>Colonic Neoplasms - prevention &amp; control</subject><subject>Colonic Neoplasms - therapy</subject><subject>Genetic Predisposition to Disease</subject><subject>Genetic Testing</subject><subject>Germ-Line Mutation</subject><subject>Humans</subject><subject>Neoplasm Staging</subject><subject>Population Surveillance</subject><subject>Precision Medicine - methods</subject><subject>Treatment Outcome</subject><issn>1548-8748</issn><issn>1548-8756</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkMtPwkAQxjdGI4ievJs9mkh1H-22eMMKasRI4uPaLNvZUNJ2625Lwt0_3DYg0dO8fvNl5kPonJJrygi5mdzfPSdtMhL0APVp4EdeFAbicJ_7UQ-dOLciRLARC49RjxPGKedhH33PLajMZabEL5BmKisBf4J1jcNzUzW5rP-NshLHJm87sSwV2Fs8tabAc2tcBap22Oi2gDWU3doQj9NVs5ZljeMlFKZegpXVZohlmeK3xq4hy_NO5xQdaZk7ONvFAfqYTt7jR2_2-vAUj2eeYsSvPaXTBeeRppxGWmjuEymCIOIs0CTVaSgDDQstiQ6I0EQB0STSUisW8NAXgvIButzqVtZ8NeDqpMicgu4IMI1LGOWR4JyRsEWvtqhqf3MWdFLZrJB2k1CSdLYnf2xv6YudcLMoIN2zvz7zHwMdfzA</recordid><startdate>20180523</startdate><enddate>20180523</enddate><creator>Hall, Michael J</creator><creator>Morris, Arden M</creator><creator>Sun, Weijing</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20180523</creationdate><title>Precision Medicine Versus Population Medicine in Colon Cancer: From Prospects of Prevention, Adjuvant Chemotherapy, and Surveillance</title><author>Hall, Michael J ; Morris, Arden M ; Sun, Weijing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c204t-cfdb338f1318f6f340a6558325f0dfd7a5febfa0f506f0ce0f08fafc253746613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Biomarkers, Tumor</topic><topic>Chemotherapy, Adjuvant</topic><topic>Colonic Neoplasms - diagnosis</topic><topic>Colonic Neoplasms - epidemiology</topic><topic>Colonic Neoplasms - prevention &amp; control</topic><topic>Colonic Neoplasms - therapy</topic><topic>Genetic Predisposition to Disease</topic><topic>Genetic Testing</topic><topic>Germ-Line Mutation</topic><topic>Humans</topic><topic>Neoplasm Staging</topic><topic>Population Surveillance</topic><topic>Precision Medicine - methods</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hall, Michael J</creatorcontrib><creatorcontrib>Morris, Arden M</creatorcontrib><creatorcontrib>Sun, Weijing</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American Society of Clinical Oncology educational book</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hall, Michael J</au><au>Morris, Arden M</au><au>Sun, Weijing</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Precision Medicine Versus Population Medicine in Colon Cancer: From Prospects of Prevention, Adjuvant Chemotherapy, and Surveillance</atitle><jtitle>American Society of Clinical Oncology educational book</jtitle><addtitle>Am Soc Clin Oncol Educ Book</addtitle><date>2018-05-23</date><risdate>2018</risdate><volume>38</volume><issue>38</issue><spage>220</spage><epage>230</epage><pages>220-230</pages><issn>1548-8748</issn><eissn>1548-8756</eissn><abstract>With the advances of technologic revolution that provides new insights into human biology, genetics and cancer, as well as advantages of big data which amasses large amounts of information for us to approach cancer treatment and prevention, we are facing challenges of organically combining data from studies based on general population and information from individual testing and setting out precisional recommendations in cancer diagnosis, prevention, and treatment. We are obligated to accelerate the adaptation of new scientific discoveries into effective treatments and prevention for cancer. In this review, we introduce our opinions on bringing knowledge of precision and population medicine together to guide our clinical practice from the prospects of colorectal cancer prevention, stage III colon cancer adjuvant therapy, and postsurgery surveillance.</abstract><cop>United States</cop><pmid>30231337</pmid><doi>10.1200/EDBK_200961</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1548-8748
ispartof American Society of Clinical Oncology educational book, 2018-05, Vol.38 (38), p.220-230
issn 1548-8748
1548-8756
language eng
recordid cdi_proquest_miscellaneous_2138633207
source MEDLINE; American Society of Clinical Oncology Online Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Biomarkers, Tumor
Chemotherapy, Adjuvant
Colonic Neoplasms - diagnosis
Colonic Neoplasms - epidemiology
Colonic Neoplasms - prevention & control
Colonic Neoplasms - therapy
Genetic Predisposition to Disease
Genetic Testing
Germ-Line Mutation
Humans
Neoplasm Staging
Population Surveillance
Precision Medicine - methods
Treatment Outcome
title Precision Medicine Versus Population Medicine in Colon Cancer: From Prospects of Prevention, Adjuvant Chemotherapy, and Surveillance
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T07%3A39%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Precision%20Medicine%20Versus%20Population%20Medicine%20in%20Colon%20Cancer:%20From%20Prospects%20of%20Prevention,%20Adjuvant%20Chemotherapy,%20and%20Surveillance&rft.jtitle=American%20Society%20of%20Clinical%20Oncology%20educational%20book&rft.au=Hall,%20Michael%20J&rft.date=2018-05-23&rft.volume=38&rft.issue=38&rft.spage=220&rft.epage=230&rft.pages=220-230&rft.issn=1548-8748&rft.eissn=1548-8756&rft_id=info:doi/10.1200/EDBK_200961&rft_dat=%3Cproquest_cross%3E2138633207%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2138633207&rft_id=info:pmid/30231337&rfr_iscdi=true